Business
KRTL Biotech Highlights Pediatric Product Line to Support Childhood Wellness and Global Public Health
KRTL Biotech Highlights Pediatric Product Line to Support Childhood Wellness and Global Public Health.
About this update from Krtl Holding Group, Inc
[{"type":"text","content":"KRTL\r\nHolding Group Inc. (OTC: KRTL) (\"KRTL Holding\" or the\r\n\"Company\") announced today that its subsidiary, KRTL Biotech, Inc.,\r\nis spotlighting its pediatric pharmaceutical portfolio, which includes a\r\nvariety of formulations tailored to the unique needs of children and infants\r\nacross Latin America. This line represents a vital component of the Company’s\r\ncommitment to accessible healthcare and international health system alignment.\r\nThe\r\npediatric catalog—developed and manufactured under GMP-certified protocols in\r\nBolivia—includes antipyretics, analgesics, antitussives, antihistamines,\r\nmultivitamins, and iron supplements, offered in syrups, drops, chewables, and\r\npowder sachets. Designed with age-appropriate dosing, flavoring, and formats,\r\nthese products meet the therapeutic and practical requirements of pediatric\r\npatients, caregivers, and physicians alike.\r\n\"Children\r\nhave specific healthcare needs, and our pediatric line is built with that\r\nsensitivity in mind,\" said Daniel Bishop, CEO of KRTL Biotech. \"From\r\nformulation to packaging, every product is created to support early\r\nintervention, better adherence, and trusted outcomes.\"\r\nThese\r\nformulations are already used in Bolivian pharmacies and clinics, and many are\r\nsupported by national procurement programs, reinforcing their safety,\r\naccessibility, and therapeutic value.\r\nKRTL\r\nBiotech is currently preparing regulatory evaluation of select pediatric\r\nproducts for U.S. market entry, including possible alignment with OTC monograph\r\npathways, where appropriate. The Company also sees strategic opportunity to\r\nsupply these pediatric medicines to health ministries and NGOs throughout the\r\nAmericas, particularly in support of public health campaigns targeting\r\nchildhood nutrition and infection management.\r\n\"Pediatric\r\ncare has always been central to our mission at SIGMA,\" said Patricia\r\nWilstermann, CEO of SIGMA. \"By delivering formulations designed\r\nspecifically for children’s needs, we aim to support families, strengthen\r\npublic health, and contribute to healthier futures for the next\r\ngeneration.\"\r\n\"Providing\r\npediatric care options that are both high quality and affordable is central to\r\nour mission,\" said Cesar Herrera, CEO of KRTL Holding Group Inc.\r\n\"This product line direct...